XClose

Cancer

Home
Menu

News

UCL cancer trials to get £9m funding boost

Cancer Research UK is planning to invest nearly £9m over the next five years into research at the Cancer Research UK & UCL Cancer Trials Centre. The announcement is part of a £45 million investment into Cancer Research UK’s network of clinical trials units across the UK, one of the charity’s largest investments in clinical research to date.

Publication date:

UCL awarded £1m for major research project on rare cancer

A UK wide research network for osteosarcoma, a rare type of bone cancer primarily affecting teenagers and young adults, is to be set up by UCL, led by Professor Adrienne Flanagan, thanks to a generous gift of £1m from The Tom Prince Cancer Trust. 

Publication date:

One cigarette a day increases cardiovascular risk

Smoking just one cigarette a day carries a much higher risk of developing coronary heart disease and stroke than expected – about half the risk of smoking 20 per day – concludes a new study published in the BMJ today. The findings could have consequences for many smokers and health professionals who believe that smoking only a few cigarettes per day bears little or no harm. 

Publication date:

Immunotherapy discovery a step towards treating T cell cancers

Researchers have discovered a new way of potentially treating mature T cell cancers using immunotherapy. The study, published in Nature Medicine, demonstrates how chimeric antigen receptor (CAR) T cells can be used to selectively target cancerous T cells.

Publication date:

New ovarian cancer drug based on UCL research

A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK. Professor Jonathan Ledermann, who led the research, said the drug was a “critical milestone” in managing the disease if the cancer recurs after chemotherapy.

Publication date: